UK News Pfizer's UK boss says he'd allow his six-year-old daughter to have it

03:50  28 november  2021
03:50  28 november  2021 Source:   dailymail.co.uk

Booster vaccine doses reduce the risk of infection by two thirds

  Booster vaccine doses reduce the risk of infection by two thirds Data from the REACT study - which randomly tested more than 100,000 people up between October 19 and November 5 - found the third doses provide a significant boost to immunity. Of the more than 8,300 people studied who had been given a booster, just 30 (0.36 per cent) became infected after immunity kicked in at two weeks. This compared to nearly 700 of the 68,000 (1.03 per cent) who had had two doses getting infected in the period.After adjusting for age and other factors, the Imperial College London researchers said this meant the odds of breakthrough infection was cut by two-thirds.

MailOnline logo © Provided by Daily Mail MailOnline logo

The boss of Pfizer in the UK is so certain of the safety of its Covid vaccine that he would allow his six-year-old daughter to have it now.

In an interview with The Mail on Sunday, Ben Osborn, who runs the British arm of the US drug giant and is head of the Association of the British Pharmaceutical Industry, said he has had ‘blunt’ conversations with those opposed to vaccines.

Asked if Pfizer’s jab, developed rapidly with German partner BioNTech was safe, he said: ‘I think the biggest reassurance I would give is that I would give the vaccine to my six-year-old daughter tomorrow if that were authorised.’

Anti-Covid-19 vaccines: the scientific council favorable to a booster dose for all

 Anti-Covid-19 vaccines: the scientific council favorable to a booster dose for all while the epidemic gains ground in France, the idea of ​​the generalization of a booster dose for all adults makes its path. © AFP.com/thomas Kienzle A Pfizer vaccine syringe against CVIV-19. The next modalities are drawn. The perspective of an anti-Covid vaccine recall for all adults in France seems to be closer, since the two bodies that advise the government during the pandemic now consider it because of the deterioration of the situation .

( © Provided by Daily Mail (

Experts and regulators in the UK are considering whether to approve the vaccine’s use in five to 11-year-olds. Pfizer’s jab was last week approved for use on children as young as five by the European Medicines Agency and is also authorised for use in American children.

Mr Osborn said he has frequently been asked about the safety of the vaccine by sceptics concerned at the speed of its development – in just 259 days.

‘It’s frustrating but it’s part of the job,’ he said. ‘The most important message is, yes, it’s been done at speed but no corners have been cut.’

( © Provided by Daily Mail (

Pfizer has also moved to address concerns that existing vaccines may not offer protection against the new Omicron variant of the virus.

The firm said yesterday it had begun running ‘neutralisation tests on the new Omicron variant of concern and expect to have initial data in the coming weeks’.

It added that if the variant escapes the protection of the vaccine, it expects ‘to be able to develop and produce a tailor-made vaccine against that variant in approximately 100 days’.

Read more

UK's Covid outbreak falls on all fronts with infections down 6.5% .
Department of Health bosses posted 39,716 new positive tests recorded over the last 24 hours, down 6.5 per cent on last Tuesday's figure of 42,484. It was the fourth day in a row cases have fallen.Dr Ugur Sahin, co-founder of the Germany-based company and Pfizer's Covid vaccine manufacturing partner, told The Wall Street Journal on Tuesday that the jab provides people with two levels of protection from the virus.

usr: 3
This is interesting!